HBOT Conversations:
Elena Schertz & Tom Fox (Part 3) – Heart Disease

Elena Schertz, NP and Tom Fox of Extivita-RTP in Raleigh, NC join us in a 5-part series to discuss the extraordinary healing they’ve witnessed through the God-given natural therapy of HBOT. This is Part 2, with a focus on how Hyperbaric Oxygen Therapy is helping people of all ages heal from concussions.

Elena Schetz, NP is the nurse practitioner, and Tom Fox is the Safety Director at Extivita-RTP. Extivita-RTP offers a positive environment for healing, and they encourage anyone seeking a better quality of life to come visit them and experience for themselves the wonder of Hyperbaric Oxygen Therapy.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

In a Special 5-part series with Extivita’s Nurse Practitioner, Elena Schertz, and Safety Director, Tom Fox, we dive into the extraordinary powers of HBOT, and the healing they have witnessed for a variety of conditions. The following segments preluding are as follows:

Part 1 – HBOT for PTSD (veteran focus)
Part 2 – Concussions & HBOT

In Part 3 of 5, we discuss heart disease and how HBOT can help. Tom explains that one of the first cardiac patients he treated with HBOT was a necrosing cardiac surgical patient who had a necrosing sternum.  The patient’s sternum was black before treatment, and after it was a fuchsia from the returned blood flow!  The cardiac surgeon’s face was priceless as he witness this patient have such an incredible response to HBOT.

Tom states, “I think a lot of the physicians that are out there today, their reason why they haven’t considered hyperbarics is because they haven’t been exposed to it. If they were exposed and they could see what it was capable of doing, it would make the difference.”

Elena informs our host that she hasn’t had anyone come to Extivita to receive HBOT specifically for heart disease, but she has witnessed patients who were getting treated for other conditions benefit from HBOT for heart health.  This is known through ejection fraction measurement, as Elena describes…

“I could say from about three people who have have reported improved ejection fraction from doing hyperbarics alone.”

di Girolamo reflects on a story where he heard from two HBOT patients in their late 60s, who had less than 50% heart function.  They started to use hyperbarics for other reasons, and discovered that after 28 HBOT treatments they now had 70% heart function.  When the Cardiologist asked with amazement, “What did you do?!”, they said we didn’t do anything — just HBOT diving.

The topic of myocarditis arises, and how HBOT can help.  Myocarditis is inflammation around the heart, and in this case, hyperbaric oxygen therapy could have an intimate role in bringing about improvement to the condition. Tom continues to explain how people want to see studies, but most of the studies out there on HBOT are simply not good.

There’s never been a lot of studies about hyperbarics, and the structure of the studies comes into question. Because when we look at the hyperbaric studies that are out there, you look and see that they’re always comparing hyperbarics to slightly pressurized room air. You’ll see that traditionally how they write it up and it could be cerebral palsy, it could be post-traumatic stress disorder, the same write up, just replace the words. Both groups improved from baseline. However, there was no differentiation between the groups.

Tom goes into a discussion about a PhD student at the University of Wisconsin who went the extra mile and looked at the therapeutic effects of hyperbaric air – hyperbaric air at 1.3, slightly pressurized room air. And what he was able to do is document mobilization of stem cells. By doing so, that encouraged the medical community to rethink hyperbaric studies using hyperbaric air as the “control”.

Tom continues to dive into HBOT and heart health in general….

“Just by basis of how hyperbarics works, you can see why that did work, how that was very helpful for these folks who had myocardial infarctions. So with with the re-oxygenation of the heart, with the stem cell mobilization, with growth of new blood vessels, you could see how the heart does start to basically regenerate and get better and heal.”

When your heart is damaged from a heart attack,  it’s like a wound in one of your organs or muscle.  Hyperbarics is known to be incredibly beneficial for wound care, 1500 hospitals across our nation have HBOT chambers that are used often simply for wound care. So, if hypoxia and the inflammation resulting from a cardiac event is causing damage to the heart, hyperbaric oxygen therapy will work to naturally resolve and remove those two things. di Girolamo stresses that you don’t have to be an expert in HBOT to understand this, and if he had a bad heart he’d most certainly be getting hyperbaric treatments, and encourages you to do the same. 

They mention that if you were to have a heart attack, inside a hyperbaric chamber is exactly where you’d want to be so you’re supersaturated with oxygen.  This leads into the reasons why it’s important to pre-condition your body with oxygen prior to heart surgery, or really even any surgery.  Tom references a study, “Research report: the effects of hyperbaric oxygen preconditioning on myocardial biomarkers of cardioprotection in patients having coronary artery bypass graft surgery” and explains that prepping your body for surgery can be critical in achieving a better outcome.

Tom explains, “The number one complication out of cardiac bypass surgery is post-cardiac surgical stroke. If you can actually precondition, you can avoid this.”

Cost savings and money for health and wellness remains a hot topic. Tom educates us that one of the chief things that has always been identified with how health care is practiced in the United States and Canada is it’s a for-profit industry.  But, if we looked at reinstituting a payment process that actually rewarded people for being healthy, managing patients, and avoiding conditions, then we could transition the current medical industrial to be incentivized to make people healthier.  If there was a way to ever do that, using hyperbaric oxygen therapy as one of the key treatments would surely be a huge leap in the right direction.

 

Guests

Elena Schertz, NP

Elena Schertz, NP - Clinic Manager at Extivita RTP

Elena attained her Bachelors of Science in Nursing from Michigan State University and received her Masters of Science in Nursing from Simmons University in Boston, MA. She has been practicing integrative medicine since 2010 and is currently working on her certification in functional medicine from the Institute of Functional Medicine.

Elena worked as a nurse in the pediatric oncology, cardiac, and surgical units at UNC hospitals for 15 years before deciding to work in integrative medicine. After years of working as a nurse, she decided to pursue her graduate degree, completing her masters with honors. She is board certified as a Family Nurse Practitioner (FNP) through the American Nurses Credentialing Center.

Elena’s passion for integrative medicine comes from her knowledge that the mind, body and psych/social/spiritual systems are not separate. The focus of Elena’s practice is to approach each of her patient’s healing process from the perspective of the whole, supported and grounded in safety and evidence-based medicine. She also maintains close consultative relationships with experts in the field to promote and enhance wellness for her patients. Elena joined the wonderful Extivita team in March 2019 and is thrilled to be a part of advancing health and wellness through hyperbaric medicine.

 

Elena Schertz, NP

Thomas M. Fox, MAS,MS, CHT - Safety Director at Extivita RTP

Tom is the Research Physiologist for the Hyperbaric Institute for Research and Training, a division of Island Hyperbaric Centre in Pincourt QC. He has worked in the field of Clinical Hyperbaric Oxygen for the last 30 years. During this time, he has been intimately involved with the implementation and the development of the US Army’s Clinical Hyperbaric Service at Dwight David Eisenhower Army Medical Center. He has provided contract hyperbaric services since 1997. Prior to accepting his current position in Quebec, Canada, Mr. Fox served as the Chief of the Atmospherics Branch of the U.S. Army School of Aviation Medicine, Fort Rucker Alabama. In this capacity, he was responsible for hyperbaric/ hypobaric operations and training of US and NATO aviators, flight surgeons and flight medics. Mr. Fox is a senior army aviator and flew twelve years as a Medical Evacuation Pilot for the US Army.

Tom joined the Extivita team in 2022 as the Safety Director, helping Extivita to maintain a healthy and safe environment for exceptional patient care.

 

Extivita-RTP – Hyperbaric Oxygen Therapy Clinic

2012-D TW Alexander Drive
Durham, NC 27709
919-354-3775
919-354-3776
contact@extivita.org
https://www.extivita.org/

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Healing under pressure: Inside a military hyperbaric chamber

Healing under pressure: Inside a military hyperbaric chamber

At 16, she had a stroke. At 17, her town burned in the Camp Fire. Now, as her community rebuilds, she's healing thanks to hyperbaric therapy. SACRAMENTO, Calif — February 2, 2017, started off as an ordinary day for the Pipkin Family. Patrick and Stacey Pipkin just...

Clinical Trial – High-flow Oxygen for Vaso-occlusive Pain Crisis

Sickle cell disease (SCD) is characterized by recurrent vaso-occlusive pain crisis (VOC),
which may evolve to acute chest syndrome (ACS), the most common cause of death among adult
patients with SCD. Currently, there is no safe and effective treatment to abort VOC or
prevent secondary ACS. Management of VOC mostly involve a symptomatic approach including
hydration, analgesics, transfusion, and incentive spirometry, which was investigated in a
very limited number of patients (<30). The polymerisation of HbS is one major feature in the pathogenesis of vaso-occlusion. Among factors determining the rate and extent of HbS polymer formation, the hypoxic stimulus is one of the most potent and readily alterable. Current guidelines recommend oxygen therapy in patients with VOC in order to maintain a target oxygen saturation of 95%. Low-flow nasal oxygen (LFNO) is routinely used to achieve this normoxia approach, particularly in patients at risk of secondary ACS because they may experience acute desaturation. In contrast, various case series suggest a potential beneficial role of intensified oxygen therapy targeting hyperoxia for the management of VOC, particularly with the use of hyperbaric oxygen, but the latter is difficult to implement in routine clinical practice. A recent high-flow nasal oxygen (HFNO) technology allows the delivery of humidified gas at high fraction of inspired oxygen (FiO2) through nasal cannula. The FiO2 can be adjusted up to 100% (allowing hyperoxia that may reverse sickling) and the flow can be increased up to 60 L/min (which generates positive airway pressure and dead space flushing, that may prevent evolution of VOC towards ACS by alleviating atelectasis and opioid-induced hypercapnia). In patients with acute respiratory failure, HFNO has been shown to improve patient's comfort, oxygenation, and survival as compared to standard oxygen or non-invasive ventilation. The aim of the present study is to test the efficacy and safety of HFNO for the management of VOC and prevention of secondary ACS. The investigators will use a multi-arm multi-stage (MAMS) design to achieve these goals. HFNO will be delivered through AIRVO 2 (Fisher and Paykel Healthcare, New Zealand), a device that incorporates a turbine allowing its use in hospital wards.

Clinical Trial – Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Subjects with Acute Myeloblastic Leukemia (AML) and myelodysplastic syndrome (MDS) who are
considered eligible for allogeneic stem cell transplant by the transplant team at WCI (Wilmot
Cancer Institute)will be enrolled in the study. Patients will receive Melphalan on day -2 and
HBO (Hyperbaric Oxygen) therapy on day 0 of the transplant. After neutrophil recovery is
documented, the patients will be seen in clinic at least weekly through day +100.